← Back to patent-cliff list
Antisense Oligonucleotides (EveryONE Medicines)
Tier C — Watch / tradeAntisense Oligonucleotides (EveryONE Medicines)
EveryONE Medicines Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Nucleic acid drug
Type
Targets：Updating
Indications (approved)：中枢神经系统紊乱
Regional status
US
-
EU
Phase II
2026-01-13
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Antisense Oligonucleotides (EveryONE Medicines)?
Approved indications include: 中枢神经系统紊乱.
When does the Antisense Oligonucleotides (EveryONE Medicines) patent expire?
No public expiry year is available for Antisense Oligonucleotides (EveryONE Medicines) yet; this page updates once verified.
How do I get a quote for Antisense Oligonucleotides (EveryONE Medicines) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29